Duloxetine Impurity 5

Duloxetine Impurity 5 is a thiol-containing byproduct arising from the alkylation step during Duloxetine synthesis, featuring a chloroethyl sulfide moiety linked to a cyclohexyl ring. Its structure incorporates a sulfur bridge between a chlorinated ethyl chain and the parent aromatic core, differing from Duloxetine by the absence of the methoxy group and the presence of a sulfide functionality. This impurity forms via nucleophilic substitution at the α-carbon during key intermediate formation. Analytically, it serves as an HPLC reference standard for impurity profiling in Duloxetine bulk drug manufacturing.